STOCK TITAN

Medifast, Inc. - MED STOCK NEWS

Welcome to our dedicated news page for Medifast (Ticker: MED), a resource for investors and traders seeking the latest updates and insights on Medifast.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Medifast's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Medifast's position in the market.

Rhea-AI Summary
Medifast reports Q2 2023 results: revenue of $296.2 million, net income of $30.3 million, EPS of $2.77. Revenue decreased 34.7% YoY, driven by decrease in active earning OPTAVIA Coaches and decline in productivity per coach. Gross profit decreased 34.5%. SG&A expenses decreased 36.9%. Company expects Q3 2023 revenue of $220M to $240M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.94%
Tags
-
Rhea-AI Summary
Medifast unveils new product line OPTAVIA ACTIVE, including exercise supplements and protein powders. The line targets new customer segments and triples the company's total addressable market by entering the $30B sports nutrition category. The products are backed by science, made with no artificial ingredients, and Informed Sport certified. Medifast also partners with Aaptiv to provide guided workouts. OPTAVIA ACTIVE will launch in September 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.68%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.8%
Tags
dividends
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.74%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.66%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.46%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.64%
Tags
none
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.64%
Tags
dividends
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.15%
Tags
management
Medifast, Inc.

NYSE:MED

MED Rankings

MED Stock Data

386.90M
9.80M
2.7%
97.45%
24.43%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
OWINGS MILLS

About MED

since 1980, medifast, inc.(nyse: med) has been a brand recommended by 20,000 doctors. developed by a physician, medifast is a clinically proven nutrition and weight loss company based in maryland. we change lives by producing results and helping those succeed. because everyone has different goals and ways of learning, we offer several support programs as you choose health with medifast. we believe that healthier people are happier people. everyone has the right to feel good about themselves. our vision is to create a world where it's easy to take control of your own well-being. we're on a mission to empower people with the right opportunities to enjoy the healthy life they deserve. we see it every day. the ear-to-ear grin. the “holding back the tears” pride. the glow of pure joy when someone reaches their weight-loss goals. their whole life gets better, and so does yours, because you helped them get there. if you’d like to spend every day helping to change people’s lives for the better